FI112652B - Menetelmä uusien terapeuttisesti käyttökelpoisten indolin-2-onijohdannaisten valmistamiseksi - Google Patents
Menetelmä uusien terapeuttisesti käyttökelpoisten indolin-2-onijohdannaisten valmistamiseksi Download PDFInfo
- Publication number
- FI112652B FI112652B FI953866A FI953866A FI112652B FI 112652 B FI112652 B FI 112652B FI 953866 A FI953866 A FI 953866A FI 953866 A FI953866 A FI 953866A FI 112652 B FI112652 B FI 112652B
- Authority
- FI
- Finland
- Prior art keywords
- group
- substituted
- unsubstituted
- compound
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6729793 | 1993-02-17 | ||
JP6729793 | 1993-02-17 | ||
JP16726293 | 1993-05-31 | ||
JP16726293 | 1993-05-31 | ||
PCT/JP1994/000235 WO1994019322A1 (en) | 1993-02-17 | 1994-02-17 | Indolin-2-one derivative |
JP9400235 | 1994-02-17 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI953866A FI953866A (fi) | 1995-08-16 |
FI953866A0 FI953866A0 (fi) | 1995-08-16 |
FI112652B true FI112652B (fi) | 2003-12-31 |
Family
ID=26408486
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI953866A FI112652B (fi) | 1993-02-17 | 1995-08-16 | Menetelmä uusien terapeuttisesti käyttökelpoisten indolin-2-onijohdannaisten valmistamiseksi |
Country Status (19)
Country | Link |
---|---|
US (5) | US5952511A (cs) |
EP (1) | EP0685463B1 (cs) |
JP (1) | JP3419539B2 (cs) |
KR (1) | KR100226310B1 (cs) |
CN (1) | CN1046268C (cs) |
AT (1) | ATE217864T1 (cs) |
AU (1) | AU6044894A (cs) |
CA (1) | CA2156287C (cs) |
CZ (1) | CZ290504B6 (cs) |
DE (1) | DE69430664T2 (cs) |
ES (1) | ES2176236T3 (cs) |
FI (1) | FI112652B (cs) |
HU (1) | HUT74105A (cs) |
MY (1) | MY128102A (cs) |
NO (1) | NO305201B1 (cs) |
PL (1) | PL176710B1 (cs) |
RU (1) | RU2128170C1 (cs) |
TW (1) | TW281669B (cs) |
WO (1) | WO1994019322A1 (cs) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6878728B1 (en) | 1999-06-11 | 2005-04-12 | Vertex Pharmaceutical Incorporated | Inhibitors of aspartyl protease |
US20040122000A1 (en) | 1981-01-07 | 2004-06-24 | Vertex Pharmaceuticals Incorporated. | Inhibitors of aspartyl protease |
IS2334B (is) | 1992-09-08 | 2008-02-15 | Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) | Aspartyl próteasi hemjari af nýjum flokki súlfonamíða |
US5783701A (en) | 1992-09-08 | 1998-07-21 | Vertex Pharmaceuticals, Incorporated | Sulfonamide inhibitors of aspartyl protease |
US5723490A (en) * | 1992-09-08 | 1998-03-03 | Vertex Pharmaceuticals Incorporated | THF-containing sulfonamide inhibitors of aspartyl protease |
PT731091E (pt) * | 1993-11-26 | 2002-05-31 | Tanabe Seiyaku Co | Derivados de 2-oxoindolina como antagonistas do receptor de colecistoquinina |
US6127372A (en) * | 1994-03-07 | 2000-10-03 | Vertex Pharmaceuticals, Incorporated | Sulfonamide inhibitors of aspartyl protease |
US5691372A (en) * | 1995-04-19 | 1997-11-25 | Vertex Pharmaceuticals Incorporated | Oxygenated-Heterocycle containing sulfonamide inhibitors of aspartyl protease |
US6004957A (en) * | 1995-06-07 | 1999-12-21 | Vertex Pharmaceuticals, Incorporated | Sulfonamide inhibitors of aspartyl protease |
AU2233097A (en) * | 1996-03-11 | 1997-10-01 | Chugai Seiyaku Kabushiki Kaisha | Process for the preparation of optically active indole compounds |
WO1998002419A1 (fr) * | 1996-07-12 | 1998-01-22 | Chugai Seiyaku Kabushiki Kaisha | Inhibiteurs de proliferation de cellules cancereuses |
US6436989B1 (en) | 1997-12-24 | 2002-08-20 | Vertex Pharmaceuticals, Incorporated | Prodrugs of aspartyl protease inhibitors |
OA11573A (en) | 1998-06-19 | 2004-07-01 | Vertex Pharma | Sulfonamide inhibitors of aspartyl protease. |
EP1135123B1 (en) * | 1998-12-04 | 2004-12-29 | Neurosearch A/S | Use of isatin derivatives as ion channel activating agents |
US6605623B1 (en) | 1998-12-18 | 2003-08-12 | Bristol-Myers Squibb Pharma Co. | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
ES2228451T3 (es) | 1999-01-29 | 2005-04-16 | Chugai Seiyaku Kabushiki Kaisha | Promotores de condrogenesis y derivados de indolin-2-ona. |
DE60041763D1 (de) * | 1999-04-23 | 2009-04-23 | Vertex Pharma | Inhibitoren von c-jun n-terminal kinasen (jnk) |
US6391907B1 (en) | 1999-05-04 | 2002-05-21 | American Home Products Corporation | Indoline derivatives |
EP1233958B1 (en) | 1999-11-23 | 2011-06-29 | MethylGene Inc. | Inhibitors of histone deacetylase |
WO2001066142A1 (fr) * | 2000-03-10 | 2001-09-13 | Chugai Seiyaku Kabushiki Kaisha | Preparations pour chondrogenese |
US7612065B2 (en) | 2000-04-21 | 2009-11-03 | Vertex Pharmaceuticals Incorporated | Inhibitors of c-JUN N-terminal kinases (JNK) |
CA2413274A1 (en) * | 2000-06-21 | 2001-12-27 | George V. Delucca | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
CA2413418A1 (en) | 2000-06-21 | 2001-12-27 | Joseph B. Santella | Piperidine amides as modulators of chemokine receptor activity |
JP4897221B2 (ja) | 2002-12-20 | 2012-03-14 | チバ ホールディング インコーポレーテッド | アミン類の合成及びその合成のための中間体 |
CN1251698C (zh) * | 2003-01-30 | 2006-04-19 | 普文英 | 一种治疗内毒素血症的板蓝根提取物和用途 |
US20080030974A1 (en) * | 2006-08-02 | 2008-02-07 | Abu-Ageel Nayef M | LED-Based Illumination System |
US20090050905A1 (en) * | 2007-08-20 | 2009-02-26 | Abu-Ageel Nayef M | Highly Efficient Light-Emitting Diode |
US20100202129A1 (en) * | 2009-01-21 | 2010-08-12 | Abu-Ageel Nayef M | Illumination system utilizing wavelength conversion materials and light recycling |
WO2011053542A1 (en) * | 2009-10-30 | 2011-05-05 | Merck Sharp & Dohme Corp. | Heterocycle amide t-type calcium channel antagonists |
CN102516153B (zh) * | 2011-12-14 | 2014-03-12 | 南京工业大学 | 5-氟吲哚-2-酮-3-脲类化合物及其制备方法和应用 |
CA2929858C (en) | 2013-11-22 | 2022-03-29 | CL BioSciences LLC | Gastrin antagonists (eg yf476, netazepide) for treatment and prevention of osteoporosis |
KR102161674B1 (ko) * | 2014-02-18 | 2020-10-05 | 주식회사 대웅제약 | 이사틴 유도체 및 이의 제조방법 |
CN113456631B (zh) * | 2021-08-06 | 2022-06-21 | 徐州医科大学 | 一种靶向acsl1的小分子药物及其在治疗子宫内膜癌中的应用 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4820834A (en) * | 1984-06-26 | 1989-04-11 | Merck & Co., Inc. | Benzodiazepine analogs |
JPS62228072A (ja) * | 1985-12-20 | 1987-10-06 | Kissei Pharmaceut Co Ltd | 3−アミノインドリン−2−オン誘導体 |
JPS62234080A (ja) * | 1985-12-20 | 1987-10-14 | Kissei Pharmaceut Co Ltd | インドリン−2−オン誘導体 |
US4760083A (en) * | 1986-04-10 | 1988-07-26 | E. I. Dupont De Nemours & Company | 3,3-disubstituted indolines |
JPS62270576A (ja) * | 1986-05-19 | 1987-11-24 | Kissei Pharmaceut Co Ltd | イサチン誘導体 |
JPS63156771A (ja) * | 1986-12-19 | 1988-06-29 | Kissei Pharmaceut Co Ltd | 3−アミノインドリン−2−オン誘導体 |
JPS62156771A (ja) * | 1986-12-19 | 1987-07-11 | Tokyo Shokai:Kk | 処方箋処理装置 |
US4876259A (en) * | 1987-01-05 | 1989-10-24 | E. I. Du Pont De Nemours And Company | 3,3-disubstituted indolines |
EP0442878A4 (en) * | 1988-04-05 | 1991-10-23 | Abbott Laboratories | Derivatives of tryptophan as cck antagonists |
ES2167312T3 (es) * | 1990-08-31 | 2002-05-16 | Warner Lambert Co | Profarmacos para antagonistas de la colecistoquinina. |
WO1992007830A2 (en) * | 1990-10-29 | 1992-05-14 | Pfizer Inc. | Oxindole peptide antagonists |
CA2055094A1 (en) * | 1990-11-13 | 1992-05-14 | Mark G. Bock | Cholecystokinin antagonist |
JPH05104510A (ja) * | 1991-10-18 | 1993-04-27 | Inax Corp | 基板へのモルタル塗布方法 |
-
1994
- 1994-02-16 TW TW083101206A patent/TW281669B/zh active
- 1994-02-16 MY MYPI94000344A patent/MY128102A/en unknown
- 1994-02-16 JP JP05654194A patent/JP3419539B2/ja not_active Expired - Fee Related
- 1994-02-17 ES ES94907058T patent/ES2176236T3/es not_active Expired - Lifetime
- 1994-02-17 KR KR1019950703395A patent/KR100226310B1/ko not_active IP Right Cessation
- 1994-02-17 RU RU95120168A patent/RU2128170C1/ru not_active IP Right Cessation
- 1994-02-17 WO PCT/JP1994/000235 patent/WO1994019322A1/ja active IP Right Grant
- 1994-02-17 HU HU9502415A patent/HUT74105A/hu unknown
- 1994-02-17 EP EP94907058A patent/EP0685463B1/en not_active Expired - Lifetime
- 1994-02-17 CN CN94191205A patent/CN1046268C/zh not_active Expired - Fee Related
- 1994-02-17 PL PL94310168A patent/PL176710B1/pl not_active IP Right Cessation
- 1994-02-17 CZ CZ19952096A patent/CZ290504B6/cs not_active IP Right Cessation
- 1994-02-17 DE DE69430664T patent/DE69430664T2/de not_active Expired - Fee Related
- 1994-02-17 AT AT94907058T patent/ATE217864T1/de not_active IP Right Cessation
- 1994-02-17 AU AU60448/94A patent/AU6044894A/en not_active Abandoned
- 1994-02-17 CA CA002156287A patent/CA2156287C/en not_active Expired - Fee Related
-
1995
- 1995-08-16 FI FI953866A patent/FI112652B/fi active
- 1995-08-17 NO NO953235A patent/NO305201B1/no unknown
-
1997
- 1997-11-03 US US08/963,547 patent/US5952511A/en not_active Expired - Fee Related
-
1998
- 1998-10-30 US US09/182,638 patent/US6031111A/en not_active Expired - Fee Related
- 1998-10-30 US US09/182,490 patent/US6207836B1/en not_active Expired - Fee Related
- 1998-10-30 US US09/182,463 patent/US6114536A/en not_active Expired - Fee Related
- 1998-10-30 US US09/182,491 patent/US6127544A/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI112652B (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten indolin-2-onijohdannaisten valmistamiseksi | |
TWI242004B (en) | 1-(1-substituted-4-piperidinyl)methyl-4-piperidine derivatives, process for producing the same, medicinal compositions containing the same and intermediates of these compounds | |
EP1105376B1 (en) | Oxindole derivatives as growth hormone releasers | |
NZ249158A (en) | N-sulphonyl-2-oxindole derivatives and pharmaceutical compositions | |
CN1980934B (zh) | 作为选择性雄激素受体调节剂(sarms)的新的吲哚衍生物 | |
KR20060114382A (ko) | 아자비시클릭 유도체, 이의 제조 방법 및 이를 함유하는약제 조성물 | |
RU2591190C2 (ru) | Новые 4-амино-n-гидроксибензамиды в качестве ингибиторов hdac для лечения рака | |
HUT69704A (en) | Isatin derivatives, process for the preparation thereof and pharmaceutical compositions comprising the same | |
IE831730L (en) | Quinoline derivatives | |
SK121397A3 (en) | Di-substituted 1,4-piperidine esters and amides having 5-ht4 antagonistic activity, producing method and their use | |
CA2022486C (en) | 1,3-dihydro-1-(pyridinylamino)-2h-indol-2-ones, a process for their preparation and their use as medicaments | |
HU198931B (en) | Process for producing 2-square brackets open /piperidin-4-yl/-methyl square brackets closed -1,2,3,4-tetradihydro-9h-pyrido/3,4-b/indole derivatives and pharma ceutical compositions comprising same | |
AU2003226579A1 (en) | Azabicyclo derivatives as muscarinic receptor antagonists | |
MXPA06013629A (es) | Derivados de tetrahidroisoquinolilsulfonamidas, su preparacion y su utilizacion en terapeutica. | |
DK157995B (da) | Analogifremgangsmaade til fremstilling af indolderivater | |
UA75060C2 (en) | Substituted n-benzyl-indole-3-yl-glyoxylic acid derivatives having antitumor activity, use thereof and pharmaceutical composition based thereon | |
EP1615634B1 (en) | Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists | |
PT85822B (pt) | Processo para a preparacao de derivados de indolo-pirazino-benzodiazepina | |
KR20050023400A (ko) | 무스카린 수용체 길항제로서의 아자비시클로 유도체 | |
MXPA06009346A (en) | Novel azabicyclic derivatives, preparation method thereof and pharmaceutical compositions containing same |